MedTrace Logo

Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study

NCT02766933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2025-01-20

No results posted yet for this study

Summary

The natural history and response to therapy of chronic hepatitis B infection in West Africa are currently poorly understood. In this study, employees of the Cameroon Baptist Convention Health Board (CBCHB) and spouses who are found to be hepatitis B positive on screening will be offered enrollment. Disease monitoring and treatment will be provided following current WHO guidelines. Clinical data will be prospectively recorded for 5 years, and bio-specimens will be frozen for future analysis.

Conditions

Sponsors & Collaborators

  • Cameroon Baptist Convention Health

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Norah Nyah, M.D. · Cameroon Baptist Convention Health Board

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766933 on ClinicalTrials.gov